A股异动丨贝瑞基因跌逾8%，控股股东高扬353.52万股将被强制变现

Core Viewpoint - Berry Genomics (000710.SZ) experienced a decline of over 8%, trading at 12.84 yuan, with a total market capitalization of 4.539 billion yuan due to the forced liquidation of shares held by its controlling shareholder, Mr. Gao Yang [1] Summary by Relevant Sections - Shareholder Actions - Mr. Gao Yang, the controlling shareholder, defaulted on a stock pledge repurchase agreement, leading to a court ruling for the forced liquidation of 3.5352 million shares, which represents 0.999% of the company's total share capital [1] - Mr. Gao Yang currently holds 24.9183 million shares, accounting for 7.05% of the company's total share capital [1] - Impact on Company - The forced liquidation is not expected to have a significant adverse effect on the company's production operations or financial status [1]